TLDR Cardano is targeting the 100-day moving average after bouncing from the 20-day MA and breaking above the 50-day MA. ADA price surged 9% after retesting theTLDR Cardano is targeting the 100-day moving average after bouncing from the 20-day MA and breaking above the 50-day MA. ADA price surged 9% after retesting the

ADA Price Aims for 100-Day Moving Average After Strong Recovery

TLDR

  • Cardano is targeting the 100-day moving average after bouncing from the 20-day MA and breaking above the 50-day MA.
  • ADA price surged 9% after retesting the 20-day moving average and reached $0.425, breaking the 50-day MA.
  • The 100-day moving average is currently at $0.489, and Cardano must overcome the $0.43 resistance level first.
  • Market analyst Nick Valdez believes the correction phase for ADA is nearing its end, signaling a potential upward move.
  • ADA price is consolidating near the 50-day moving average, with support at this level potentially setting the stage for further gains.

Cardano’s (ADA) price is eyeing a move toward the 100-day moving average (MA) after showing resilience against other key moving averages. ADA has bounced from the 20-day MA and recently broke above the 50-day MA, creating optimism for the next target. Market analyst Nick Valdez (Deezy) believes the 100-day MA, currently sitting at $0.489, is Cardano’s next major hurdle.

ADA Bounces from the 20-Day and Breaks Above the 50-Day MA

Cardano’s recent price action indicates bullish momentum after a series of moves above key moving averages. ADA price bounced from the 20-day moving average in early January, signaling recovery. After retesting this level, Cardano surged 9% the following day, reaching $0.425 and breaking above the 50-day MA, which had previously served as resistance.

Despite this recent strength, ADA retraced slightly to $0.403, currently consolidating near the 50-day MA, which is at $0.395. If the price continues to hold above this level, it could potentially target the next resistance at $0.43. Market analysts, including Deezy, are watching this consolidation phase closely, as it could set the stage for another upward move.

The 100-Day MA: A Key Target for ADA Price

Deezy, a well-known market analyst, points out that the 100-day moving average is now the next major target for Cardano. With the 100-day MA currently at $0.489, ADA needs to overcome the $0.43 resistance level first. Although ADA has faced selling pressure around $0.43 multiple times this month, breaking through this resistance could open the door for a push toward the 100-day MA.

ADA PriceDeezy (Nick Valdez): X

Despite the market’s unpredictability, Deezy believes the correction phase for ADA may be nearing its end. He notes that ADA has formed a higher low on the daily chart, suggesting that the correction might be over. If Cardano manages to maintain support at the 50-day MA and hold above the $0.43 resistance, a potential rally towards the 100-day MA seems plausible.

Deezy further explains that ADA’s price action could be signaling an upcoming surge. If the current consolidation phase results in a break above $0.43, Cardano might continue its upward trajectory toward the 100-day MA. However, the price must maintain support at the 50-day MA to ensure that the momentum continues.

The post ADA Price Aims for 100-Day Moving Average After Strong Recovery appeared first on CoinCentral.

Market Opportunity
Cardano Logo
Cardano Price(ADA)
$0.3935
$0.3935$0.3935
-1.60%
USD
Cardano (ADA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.